Pain comes from communication between nerves, the spinal cord, and the brain. Pain may be acute, chronic, neuropathic, or nociceptive. Acute pain is sudden and usually linked to injury, then improves ...
Najat Khan, CEO, opened by stating that Recursion is at an important inflection point, harnessing its integrated AI-driven platform to "translate insights into evidence; evidence that this platform, ...
Nvidia disclosed in recent regulatory filings that it had fully exited its roughly two‑year, 7.71 million‑share investment in Recursion Pharmaceuticals, while Cathie Wood’s ARK Invest simultaneously ...
Earlier in December 2025, Recursion Pharmaceuticals reported positive Phase 1b/2 TUPELO trial data for REC-4881 in familial adenomatous polyposis, showing rapid and durable reductions in polyp burden ...
When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
In software engineering as in all technical work, we find ourselves writing definitions of the concepts we need to work on. Often, such definitions leave much to be desired. In two earlier BLOG@CACM ...
Singer and rapper Example suffered a blunder during a recent gig after telling a woman to “get up and dance”, apparently not realising she was pregnant and disabled. Footage of the awkward moment was ...
After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results